Nifty

:

24334.20

Sensex

:

80242.24

-1.75 (-0.01%)
-46.14 (-0.06%)

Login

Nifty
Sensex

:
:

24334.20
80242.24

-1.75 (-0.01%)
-46.14 (-0.06%)

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

N/A

BSE: 524558 | NSE: NEULANDLAB

Watchlist

NSE BSE

14484.45

06-Feb-2025

Open
High
Low
Previous Close

15020.00
15220.00
14357.65
14817.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

20554
3036.26
18100.00
5540.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15,443.21
51.50
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,450.36
0.12%
10.32

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.76
15.36
17.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.38
35.34
26.53

PAT CAGR (%)

10 Years
5 Years
3 Years

34.11
79.26
67.53

P:E (Median)

8 Years
5 Years
3 Years

32.49
28.90
26.49

P:BV (Average)

8 Years
5 Years
3 Years

3.94
4.60
6.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.74
17.85
20.52

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 233.89 250.46 385.6 490.56
P/E Ratio 68.7 64.16 41.67 32.76
Revenue 1516 1641 2163 2686
EBITDA 463 467 711 896
Net Income 300 308 497 633
ROA 17.6
P/B Ratio 16.07 12.96 9.92 7.63
ROE 26.36 21.39 26.96 26.33
FCFF 112.02 287.93 358.15 435.04
FCFF Yield 0.59 1.5 1.87 2.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11% 385.01 407.07 -5.42%
Expenses 311.66 272.26 14.47% 249.50 280.45 -11.04% 315.78 265.73 18.83% 278.22 287.36 -3.18%
EBITDA 86.38 120.56 -28.35% 61.34 137.30 -55.32% 123.83 97.27 27.31% 106.79 119.72 -10.80%
EBIDTM 21.70% 30.69% 19.73% 32.87% 28.17% 26.80% 27.74% 29.41%
Other Income 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78% 5.36 8.06 -33.50%
Interest 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81% 3.61 4.29 -15.85%
Depreciation 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79% 16.46 13.47 22.20%
PBT 127.55 103.78 22.90% 48.54 121.41 -60.02% 130.31 83.50 56.06% 92.08 110.02 -16.31%
Tax 26.15 23.08 13.30% 16.58 32.34 -48.73% 31.97 21.28 50.23% 24.47 25.51 -4.08%
PAT 101.39 80.70 25.64% 31.96 89.06 -64.11% 98.34 62.22 58.05% 67.61 84.51 -20.00%
PATM 25.47% 20.54% 10.28% 21.32% 22.37% 17.14% 17.56% 20.76%
EPS 79.21 63.05 25.63% 24.97 69.58 -64.11% 76.83 48.61 58.05% 52.82 66.02 -19.99%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11% 385.01 407.07 -5.42%
Expenses 311.43 271.56 14.68% 248.62 280.26 -11.29% 316.24 266.07 18.86% 278.09 287.21 -3.18%
EBITDA 86.60 121.27 -28.59% 62.23 137.49 -54.74% 123.36 96.92 27.28% 106.92 119.86 -10.80%
EBIDTM 21.76% 30.87% 20.02% 32.91% 28.06% 26.70% 27.77% 29.44%
Other Income 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78% 5.36 8.06 -33.50%
Interest 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81% 3.61 4.29 -15.85%
Depreciation 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79% 16.46 13.47 22.20%
PBT 127.77 104.48 22.29% 49.42 121.59 -59.36% 129.84 83.16 56.13% 92.20 110.16 -16.30%
Tax 26.18 23.09 13.38% 16.58 32.35 -48.75% 31.97 21.28 50.23% 24.64 25.62 -3.83%
PAT 101.59 81.39 24.82% 32.84 89.25 -63.20% 97.87 61.88 58.16% 67.56 84.54 -20.09%
PATM 25.52% 20.72% 10.57% 21.36% 22.26% 17.05% 17.55% 20.77%
EPS 78.75 63.09 24.82% 25.46 69.18 -63.20% 75.86 47.96 58.17% 52.37 65.53 -20.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,533.48 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 Net Sales Growth -2.98% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% Cost Of Goods Sold 598.24 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 Gross Profit 935.24 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 GP Margin 60.99% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% Total Expenditure 1,155.16 1,096.66 919.89 808.88 790.47 661.25 608.96 477.38 473.20 430.10 402.79 Power & Fuel Cost - 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 % Of Sales - 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% Employee Cost - 248.53 194.84 175.76 144.02 118.48 104.47 95.73 84.92 59.89 49.16 % Of Sales - 15.95% 16.36% 18.48% 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% 10.48% Manufacturing Exp. - 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 % Of Sales - 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% General & Admin Exp. - 57.05 48.24 34.50 37.42 25.18 24.56 30.38 25.23 26.90 20.77 % Of Sales - 3.66% 4.05% 3.63% 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% 4.43% Selling & Distn. Exp. - 47.24 40.25 36.00 42.38 26.59 28.01 26.50 23.14 26.41 20.31 % Of Sales - 3.03% 3.38% 3.79% 4.52% 3.49% 4.20% 5.02% 4.00% 5.18% 4.33% Miscellaneous Exp. - 10.04 22.77 9.12 11.93 13.21 8.76 4.91 6.34 1.89 20.31 % Of Sales - 0.64% 1.91% 0.96% 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% 0.53% EBITDA 378.34 461.92 271.31 142.20 146.44 101.46 57.87 50.03 105.69 79.87 66.36 EBITDA Margin 24.67% 29.64% 22.78% 14.95% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% 14.14% Other Income 18.41 12.54 9.75 2.08 16.09 3.89 3.49 4.53 1.17 1.62 0.78 Interest 9.56 14.00 13.07 13.49 17.90 21.57 15.66 18.92 21.08 24.47 27.35 Depreciation 65.11 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 PBT 398.48 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 Tax 99.17 101.17 52.09 18.21 24.67 36.62 3.69 1.73 20.17 14.87 8.70 Tax Rate 24.89% 25.24% 24.20% 22.28% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% 35.54% PAT 299.30 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 PAT before Minority Interest 299.30 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.52% 19.22% 13.69% 6.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% 3.36% PAT Growth -5.43% 83.67% 156.76% -20.87% 405.60% -1.61% 36.66% -74.54% 75.62% 67.36% EPS 233.83 234.06 127.44 49.63 62.73 12.41 12.61 9.23 36.23 20.63 12.33

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,533.48 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 Net Sales Growth -2.98% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% Cost Of Goods Sold 598.24 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 Gross Profit 935.24 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 GP Margin 60.99% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% Total Expenditure 1,154.38 1,095.99 919.36 808.46 790.09 660.82 608.46 476.98 472.55 429.52 402.53 Power & Fuel Cost - 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 % Of Sales - 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% Employee Cost - 257.06 201.79 182.47 149.74 123.56 110.46 102.99 92.74 65.38 51.81 % Of Sales - 16.49% 16.94% 19.19% 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% 11.04% Manufacturing Exp. - 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 % Of Sales - 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% General & Admin Exp. - 60.91 51.22 35.80 38.93 27.75 27.49 33.32 28.30 29.72 23.59 % Of Sales - 3.91% 4.30% 3.76% 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% 5.03% Selling & Distn. Exp. - 33.94 29.58 27.40 34.63 18.30 18.28 14.04 11.16 17.52 14.54 % Of Sales - 2.18% 2.48% 2.88% 3.70% 2.40% 2.74% 2.66% 1.93% 3.44% 3.10% Miscellaneous Exp. - 10.29 22.99 9.28 12.08 13.42 9.08 6.77 6.78 1.89 14.54 % Of Sales - 0.66% 1.93% 0.98% 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% 0.54% EBITDA 379.11 462.59 271.84 142.62 146.82 101.89 58.37 50.43 106.34 80.45 66.62 EBITDA Margin 24.72% 29.68% 22.82% 15.00% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% 14.20% Other Income 18.41 12.54 9.75 2.08 16.10 3.89 3.49 4.53 1.17 1.78 0.78 Interest 9.56 14.00 13.07 13.50 17.90 21.57 15.66 18.93 21.09 24.48 27.36 Depreciation 65.11 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 PBT 399.23 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 Tax 99.37 101.36 52.23 18.34 24.70 36.71 3.90 1.87 20.32 14.92 8.79 Tax Rate 24.89% 25.25% 24.21% 22.32% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% 35.56% PAT 299.86 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.33 15.94 PAT before Minority Interest 299.86 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.08 15.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.01 PAT Margin 19.55% 19.25% 13.73% 6.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% 3.40% PAT Growth -5.42% 83.51% 156.22% -20.85% 397.41% -1.40% 36.32% -74.26% 71.46% 71.46% EPS 234.27 234.44 127.75 49.86 62.99 12.66 12.84 9.42 36.61 21.35 12.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,276.54 988.36 835.57 781.88 705.55 695.58 554.78 542.78 184.17 159.83 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 Total Reserves 1,263.64 975.46 822.67 768.98 692.64 682.68 234.98 222.97 175.22 150.87 Non-Current Liabilities 120.59 145.22 178.42 168.68 162.21 103.13 145.78 53.83 69.01 54.58 Secured Loans 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 Long Term Provisions 7.13 9.83 11.45 9.10 12.18 11.74 9.87 9.28 6.85 6.38 Current Liabilities 433.80 445.75 368.13 372.96 361.99 331.19 370.38 288.24 270.16 296.76 Trade Payables 198.54 177.99 122.65 156.75 120.00 124.00 129.01 88.64 86.17 111.76 Other Current Liabilities 233.63 244.71 152.05 158.59 71.55 57.33 40.57 47.11 54.90 33.16 Short Term Borrowings 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 Short Term Provisions 1.64 11.89 1.21 0.64 2.27 0.80 1.59 1.41 5.47 6.04 Total Liabilities 1,830.93 1,579.33 1,382.12 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 511.17 Net Block 804.63 738.19 747.70 696.92 622.75 511.67 445.01 435.74 138.77 123.07 Gross Block 1,075.84 953.24 913.24 826.45 714.31 575.42 483.45 454.74 291.78 263.65 Accumulated Depreciation 271.22 215.05 165.54 129.53 91.56 63.75 38.44 19.00 153.00 140.58 Non Current Assets 911.46 819.00 802.87 775.34 715.91 676.96 624.22 510.60 210.00 196.04 Capital Work in Progress 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 Non Current Investment 1.44 0.68 0.66 19.50 30.33 30.37 30.37 30.36 7.55 7.67 Long Term Loans & Adv. 40.31 20.21 14.40 41.66 35.78 30.45 22.52 24.69 22.71 23.83 Other Non Current Assets 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 Current Assets 919.47 760.34 579.25 548.18 513.83 452.93 446.73 374.24 313.34 315.13 Current Investments 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 Inventories 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 Sundry Debtors 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 Cash & Bank 115.29 58.65 18.99 18.08 45.69 37.35 17.05 12.04 9.04 6.49 Other Current Assets 80.23 13.66 11.39 8.76 51.21 51.41 53.17 38.47 58.53 66.39 Short Term Loans & Adv. 61.96 47.03 45.95 49.54 33.79 31.77 36.93 25.03 46.54 45.17 Net Current Assets 485.67 314.59 211.12 175.22 151.84 121.74 76.35 86.00 43.18 18.37 Total Assets 1,830.93 1,579.34 1,382.12 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34 511.17

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,282.70 994.10 840.50 786.46 709.96 699.31 558.04 545.62 186.63 161.38 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 Total Reserves 1,269.80 981.20 827.60 773.56 697.06 686.41 238.24 225.81 177.68 152.42 Non-Current Liabilities 122.17 146.71 179.83 169.82 163.39 104.06 146.43 54.37 69.42 54.76 Secured Loans 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 Long Term Provisions 7.61 10.29 11.91 9.44 12.49 11.91 9.87 9.28 6.85 6.38 Current Liabilities 427.68 438.96 363.16 368.51 357.63 326.98 366.93 285.60 268.00 295.14 Trade Payables 191.96 171.01 117.38 152.13 115.56 119.68 124.29 85.92 83.86 111.81 Other Current Liabilities 234.01 244.87 152.35 158.75 71.63 57.45 41.83 47.18 55.02 31.28 Short Term Borrowings 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 Short Term Provisions 1.72 11.93 1.21 0.64 2.27 0.80 1.59 1.41 5.50 6.25 Total Liabilities 1,832.55 1,579.77 1,383.49 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 511.53 Net Block 804.64 738.19 747.70 696.94 622.76 511.69 445.01 435.74 138.77 123.07 Gross Block 1,072.98 950.36 913.27 826.48 714.33 575.44 483.45 454.74 291.78 263.65 Accumulated Depreciation 268.34 212.17 165.57 129.54 91.57 63.75 38.44 19.00 153.00 140.58 Non Current Assets 911.48 818.87 802.70 775.20 715.79 676.88 624.20 510.54 209.87 195.76 Capital Work in Progress 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 Non Current Investment 1.28 0.52 0.50 19.35 30.17 30.21 30.21 30.20 7.39 7.39 Long Term Loans & Adv. 40.47 20.24 14.38 41.67 35.81 30.51 22.66 24.79 22.73 23.83 Other Non Current Assets 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 Current Assets 921.08 760.89 580.79 549.59 515.19 453.47 447.19 375.04 314.19 315.77 Current Investments 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 Inventories 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 Sundry Debtors 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 Cash & Bank 116.80 59.10 20.36 19.40 46.98 37.84 17.26 12.49 9.71 6.98 Other Current Assets 80.33 13.70 11.52 8.84 51.27 51.46 53.43 38.83 58.70 66.53 Short Term Loans & Adv. 62.03 47.09 46.00 49.55 33.80 31.77 37.15 25.30 46.68 45.23 Net Current Assets 493.40 321.94 217.64 181.08 157.55 126.49 80.27 89.45 46.18 20.63 Total Assets 1,832.56 1,579.76 1,383.49 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06 511.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 260.06 238.53 60.41 189.28 56.63 69.60 11.52 38.89 44.65 13.07 PBT 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 Adjustment 62.07 77.93 66.18 40.17 58.14 38.93 40.35 43.95 33.85 36.35 Changes in Working Capital -91.22 -11.04 -66.99 49.34 -49.30 15.92 -39.20 -55.25 -18.76 -38.74 Cash after chg. in Working capital 371.63 282.10 80.93 194.47 61.33 74.68 14.69 55.25 56.38 22.08 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -111.57 -43.57 -20.53 -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 -9.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -149.67 -61.50 -95.53 -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 -14.13 Net Fixed Assets -127.92 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 Net Investments -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 Others -20.99 -4.75 -27.45 9.35 9.45 -6.87 18.92 130.28 7.16 -2.08 Cash from Financing Activity -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.86 -0.08 -23.62 1.15 Net Cash Inflow / Outflow 41.11 41.24 2.60 -8.80 2.47 4.36 0.09 -3.30 1.18 0.08 Opening Cash & Equivalents 44.96 3.72 1.12 9.92 7.44 3.08 3.00 6.29 0.32 0.23 Closing Cash & Equivalent 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 1.49 0.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 261.18 237.21 60.39 189.36 57.34 69.91 11.27 38.68 44.83 13.17 PBT 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 Adjustment 62.08 77.93 66.30 40.08 58.28 39.11 40.43 43.96 33.73 36.34 Changes in Working Capital -90.73 -12.83 -67.58 49.22 -49.17 15.47 -40.02 -55.94 -19.17 -38.76 Cash after chg. in Working capital 372.78 280.84 80.88 194.63 62.03 74.91 14.35 55.20 56.56 22.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -111.60 -43.63 -20.49 -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 -9.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -149.69 -61.50 -95.52 -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 -14.13 Net Fixed Assets -127.92 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 Net Investments -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 Others -21.01 -4.75 -27.44 9.35 9.45 -6.88 18.92 130.28 7.16 -2.08 Cash from Financing Activity -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.85 -0.09 -23.62 1.15 Net Cash Inflow / Outflow 42.21 39.92 2.59 -8.72 3.18 4.66 -0.17 -3.51 1.35 0.19 Opening Cash & Equivalents 45.42 5.09 2.44 11.20 7.94 3.29 3.44 6.97 0.81 0.62 Closing Cash & Equivalent 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 2.16 0.81

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 994.26 769.65 650.56 608.71 549.21 541.45 273.54 260.03 206.30 178.97 ROA 17.57% 11.02% 4.70% 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% 3.17% ROE 26.48% 17.90% 7.86% 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% 11.25% ROCE 33.62% 20.99% 9.44% 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% 15.74% Fixed Asset Turnover 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 Receivable days 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 Inventory Days 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 Payable days 119.04 114.73 120.79 115.20 67.56 78.05 84.05 68.43 85.33 91.74 Cash Conversion Cycle 40.79 60.01 64.36 55.20 115.76 120.56 152.27 106.08 86.78 82.31 Total Debt/Equity 0.06 0.12 0.28 0.22 0.37 0.33 1.31 0.83 0.99 1.18 Interest Cover 29.63 17.47 7.06 6.86 3.43 2.27 1.72 4.16 2.69 1.90

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 999.07 774.12 654.40 612.28 552.65 544.35 277.21 263.23 209.07 180.72 ROA 17.59% 11.04% 4.71% 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% 3.20% ROE 26.38% 17.84% 7.85% 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% 11.24% ROCE 33.51% 20.94% 9.44% 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% 15.75% Fixed Asset Turnover 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 Receivable days 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 Inventory Days 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 Payable days 114.75 110.05 116.52 111.44 65.43 75.72 82.06 67.03 85.01 92.70 Cash Conversion Cycle 45.08 64.68 68.63 58.96 117.88 122.89 154.27 107.48 87.10 81.35 Total Debt/Equity 0.06 0.12 0.28 0.22 0.37 0.33 1.30 0.82 0.98 1.17 Interest Cover 29.68 17.51 7.09 6.89 3.45 2.30 1.74 4.19 2.72 1.90

Top Investors:

malabar india fund limited

mukul mahavir agrawal

hsbc focused fund

icici prudential flexicap fund

matthews india fund

jupiter india fund

kedia securities private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Neuland Laboratories - Quarterly Results
10th Feb 2025, 16:27 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback